🕒 Tuesday 26 August 2025 Tue, 26 Aug 2025

Tribeca Global Natural Resources Limited (ASX – TGF) has declared a fully franked 5-cent dividend for FY25 alongside a 10% on-market buyback, while delivering returns that outpaced major natural resource indices. The company’s portfolio is well positioned to benefit from rising strategic demand for critical and precious metals amid evolving global market dynamics.

Integrated Research reported steady pro-forma revenue in FY25 despite declines in statutory revenue and profits, driven by a softer renewals book and market uncertainty. The company’s product-led growth strategy gained momentum with new product launches and a major contract renewal.

Integrated Research Limited reported an 18% revenue decline and a 51% drop in net profit for FY25, while unveiling a strategic pivot towards AI-driven product innovation and cloud services.

Imugene Limited reported a significant 54% reduction in net loss for FY25, driven by cost efficiencies and promising clinical progress in its immuno-oncology pipeline. The company’s lead asset, azer-cel, achieved a 79% response rate in Phase 1b trials and secured FDA Fast Track designation.

Kaili Resources has responded to ASX inquiries following volatile trading, confirming imminent rare earth element drilling in South Australia and revealing detailed shareholder data.

Kaili Resources has responded to an ASX price query following a dramatic rise in its share price, denying any undisclosed material information and confirming full compliance with ASX listing rules.

Mader Group has delivered record FY25 results with revenue climbing 13% to $872.2 million and net profit rising 13%, setting the stage for a $1 billion revenue target in FY26.

Carindale Property Trust reported a solid 7.8% increase in funds from operations for FY25, supported by near-full occupancy and rising retail sales at Westfield Carindale. Distributions grew 5%, aligning with guidance.

Carindale Property Trust reported a solid 6.4% increase in revenue to $61.6 million and a significant jump in net profit to $39.2 million for the year ended 30 June 2025, underpinned by strong property valuations and operational performance.

Chrysos Corporation has confirmed its FY25 financial results, reporting $66.1 million in revenue and $16.1 million EBITDA, while reinforcing its commitment to advancing its PhotonAssay technology for mining analysis.

Gorilla Gold reports exceptional high-grade drill results extending beyond its recent 350,000-ounce Mulwarrie resource estimate, setting the stage for a significant resource upgrade later this year.

CleanSpace Holdings posted a robust 26% revenue increase in FY25, turning the corner to positive EBITDA and cash flow in the second half, driven by strong industrial market demand and operational efficiencies.

Kip McGrath Education Centres Limited reported modest revenue growth and a solid increase in EBITDA for FY25, despite a significant net loss driven by its exit from the US market. The company declared a fully franked final dividend, signaling confidence in its refocused core business.

Peninsula Energy Limited has had its ASX trading suspension lifted following the completion of a placement and institutional entitlement offer, signaling renewed market activity.

EMVision Medical Devices is set to activate its sixth and final pivotal trial site at UCLA Health, advancing its emu™ brain scanner towards FDA submission. Meanwhile, the Continuous Innovation Study grows with the addition of Box Hill Hospital.

Tyro Payments Limited reported FY25 results with strong top-line growth and margin expansion, setting a confident outlook for FY26 backed by AI-driven efficiency and an expanded market.

Peninsula Energy has successfully completed the first tranche of a fully underwritten A$69.9 million equity raise, securing strong institutional support including cornerstone investors Tees River and Davidson Kempner. The company now opens its retail entitlement offer to shareholders, aiming to fund the ramp-up of uranium production at its Lance Project in Wyoming.

Tyro Payments delivered solid FY25 results with a 10.6% rise in EBITDA and accelerated growth initiatives, including expansion into new $40 billion addressable markets and a pilot banking platform.

Tyro Payments reported modest transaction growth and a 10.6% rise in EBITDA for FY25, while preparing for a CEO change and expanding into new industry verticals.

Chrysos Corporation reported a robust FY25 with 46% revenue growth and an 80% jump in EBITDA, driven by expanding adoption of its PhotonAssay technology and a landmark contract with gold giant Newmont. The company projects further growth in FY26 with revenue guidance of $80-90 million.

Amplia Therapeutics has successfully raised A$2.65 million through its Share Purchase Plan, exceeding expectations and bolstering funding for pivotal clinical trials of its lead drug narmafotinib.

Ballard Mining reports strong infill and extensional drilling results at its Mt Ida Gold Project, confirming and potentially expanding the high-grade Baldock resource. The ongoing program aims to upgrade resource confidence and supports future development plans.

Omega Oil and Gas confirms the commercial viability of its Canyon Sandstone reservoir in Queensland’s Taroom Trough, with SLB modelling indicating nearly 1 million barrels of oil equivalent per well and significant upside potential.

CleanSpace Holdings Limited reported a 26% increase in revenue to $19.8 million for FY25, alongside a significant reduction in net loss to $478,276. The company’s strategic expansion and innovation efforts underpin its improving financial health and global market presence.